Effect lipid peroxidation subarachnoid clot present study effect malondialdehyde by-product lipid peroxidation subarachnoid clot Eighteen cynomolgus monkeys groups groups doses mg/kg placebo-treated group monkey underwent baseline cerebral angiography right-sided craniectomy placement subarachnoid clot middle cerebral artery MCA Treatment hours days Seven days experimental subarachnoid hemorrhage SAH angiography animals placebo-treated group significant vasospasm MCA side clot treatment dosages vasospasm clot-side MCA content malondialdehyde thiobarbituric acid test high-performance liquid chromatography HPLC methods HPLC accurate thiobarbituric acid test measurement low concentrations malondialdehyde placebo-treated group malondialdehyde content Day clot contrast content prepared clot low group malondialdehyde content clot Day placebo-treated group malondialdehyde content clot mg/kg group placebo Malondialdehyde actual vessel wall MCA group results lipid peroxidation subarachnoid clot role pathogenesis vasospasm salutary effects vasospasm reduction lipid peroxidation SAH 